AnalystsChris RaymondChris Raymond's Stock Forecasts
AnalystsChris Raymond
Sectors:
Industries:
Analyst Ranking
Top 29%
#1559 out of 5511 analysts
Average Return
+54.35%
Win Rate
67%6 out of 9
Risk vs Reward
Poor
Good
Chris Raymond's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | +221.13% | $36.21 | $116.28 | 2025-09-03 - 2026-09-02 | Strong Buy |
Cogent Biosciences IncCOGT | +164.30% | $13.08 | $34.57 | 2025-09-03 - 2026-09-02 | Strong Buy |
Tyra Biosciences IncTYRA | +103.98% | $12.32 | $25.13 | 2025-09-03 - 2026-09-02 | Strong Buy |
Nuvalent IncNUVL | +55.85% | $79.54 | $123.96 | 2025-09-03 - 2026-07-15 | Buy |
Monopar TherapeuticsMNPR | +30.06% | $78.00 | $101.45 | 2025-11-14 - 2026-09-16 | Buy |
Chris Raymond Analyst Color
Get additional color on Chris Raymond's coverage of popular stocks
Chris Raymond's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | 3 | Buy | $123.00 | +21.24% | Downgrades | 10 months ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | a year ago |
Tyra Biosciences IncTYRA | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Nuvalent IncNUVL | 1 | Buy | $105.00 | N/A | Initiates Coverage On | a year ago |
Kalaris Therapeutics IncKLRS | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | a year ago |
Cogent Biosciences IncCOGT | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Biohaven LtdBHVN | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.